Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Crucell partners with ADImmune on flu vaccine
Under the terms of the deal, ADImmune will use Crucell's virosome technology to produce a virosomal adjuvanted influenza vaccine for the three markets. Additionally, ADImmune will produce influenza
Under the terms of the deal, ADImmune will use Crucell's virosome technology to produce a virosomal adjuvanted influenza vaccine for the three markets. Additionally, ADImmune will produce influenza
Tamiflu, made by Roche, has been associated with abnormal behaviour in teenagers, although no causal link has been found. Since 2004, a total of 15 young people have
PD-02 is an ultra-pure form of creatine made under strictly controlled drug manufacturing guidelines to not contain harmful neurotoxins that may be present in common types of creatine.
According to the Reuters news agency, the decision follows an original ruling in February 2006 when Judge Denise Cote ruled that Takeda's patent on diabetes drug Actos was
Shire said that the lawsuit results from an abbreviated new drug application filed by Colony for generic versions of 5mg, 10mg, 15mg, 20mg, 25mg and 30mg Adderall XR.
The Israeli-based company had argued that the patents are invalid because prior inventions made the technology “obvious” and because Celebrex was covered by an earlier patent. However, the
BL-4020 is a peptide designed to function as an anti-inflammatory agent in various diseases such as allergic asthma and colitis. In preclinical trials conducted at the Hebrew University
ATC is Avexa’s novel nucleoside reverse transcriptase inhibitor (NRTI) being developed for the treatment of HIV infection in patients with drug-resistant HIV. The phase IIb trial compared the
The trial in healthy volunteers will compare a single, subcutaneously administered, fixed dose of GlycoPEG-GCSF versus the approved fixed dose of Amgen’s Neulasta, the only currently marketed long-acting
The trial is designed to evaluate the safety, tolerability and immunogenicity of ChimeriVax-West Nile in older adults and is being conducted in the US. The randomized, double-blind, placebo-controlled